DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Programme Preview
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • Exhibition & Sponsorship Opportunities
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
  • The Aerosol Society logo
Akash Bijlani

Akash Bijlani

Strategy Access Solutions

Akash Bijlani is the CEO and Founder of Strategy Access Solutions, a global health economics and market access consultancy. I am responsible for:

1. Identifying evidence gaps (clinical, economic, and operational) and implementing plans to address these gaps.
2. Leading clinical and health economic studies.
3. Collaborating with global health technology assessment (HTA) organizations, key opinion leaders (KOLs), clinicians, partners, specialty societies, and patient organizations to understand the clinical and health economic value of the particular therapy / technology.
4. Working with in-country partners to obtain HTA or payer approval, coding, coverage, and payment to drive product adoption.
5. Expanding use of new products / therapies globally to support improved patient clinical outcomes.

I hold a Master of Public Health (MPH) in International Health and Development from Tulane University and a Bachelor of Arts (BA) in Sociology from the University of Chicago. Before my role at Strategy Access Solutions, I worked at Aptar Digital Health (part of Aptar Pharma) and two medical device companies, overseeing global health economics and market access. Earlier in my career, I served as a hospital administrator at three United States academic medical centers.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk